Navigation Links
Oncothyreon announces temporary suspension of Stimuvax clinical trials by Merck Serono
Date:3/23/2010

The INSPIRE study is a multi-national, Phase 3, double-blind, placebo-controlled, randomized clinical trial designed to evaluate the efficacy, safety and tolerability of Stimuvax in subjects suffering from unresectable, stage III NSCLC and demonstrating either stable disease or objective response following primary chemo-radiotherapy. The study will enroll approximately 420 unresectable, stage III NSCLC patients across China, Hong Kong, Korea, Singapore and Taiwan.

STRIDE is a randomized, double-blind, controlled, multi-center Phase III study designed to determine if Stimuvax(R) can extend progression free survival in patients treated with hormonal therapy who have inoperable, locally advanced, recurrent or metastatic breast cancer. Overall survival, quality of life, tumor response and safety will also be assessed in this study.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit

SOURCE Oncothyreon Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement
2. Oncothyreons PX-866 PI-3 kinase inhibitor named among Top 10 most promising oncology products for partnering by Windhover
3. Oncothyreon reports third quarter 2009 financial results & provides product pipeline update
4. Oncothyreon announces webcast of third quarter 2009 financial results conference call
5. Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors
6. Oncothyreon to present at Rodman Renshaw Global Healthcare Conference
7. Oncothyreon reports second quarter 2009 financial results
8. Oncothyreon announces closing of $15.0 million registered direct financing
9. Oncothyreon announces webcast of second quarter 2009 financial results conference call
10. Oncothyreon appoints Diana Hausman as Vice President of Clinical Development
11. Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 The Pistoia Alliance ... HELM biomolecular representation standard software toolkit and editor ... HELM (Hierarchical Editing Language for Macromolecules) enables ... (e.g. proteins, nucleotides, antibody drug conjugates) whose size ... methodologies impractical or unusable. HELM solves this problem ...
(Date:6/18/2013)... June 18, 2013 ... research firm, announces the initiation of full ... biopharmaceutical company developing and marketing products for ...      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... examining the investment merits of BioAlliance Pharma, ...
(Date:6/18/2013)... DALLAS , June 18, 2013 ... Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) ... analyzes and studies the Major Market Drivers, Restraints, and Opportunities ... , Asia-Pacific and Rest of ... Data Tables 22 Figures ...
(Date:6/18/2013)... MINNEAPOLIS , June 18, 2013  Techne ... today that it has agreed to acquire 100% ... subsidiary Bionostics, Inc. (Bionostics).  Bionostics is a global ... control solutions that verify the proper operation of ... utilized in point of care blood glucose and ...
Breaking Biology Technology:The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Techne Corporation Announces Acquisition Agreement 2Techne Corporation Announces Acquisition Agreement 3Techne Corporation Announces Acquisition Agreement 4Techne Corporation Announces Acquisition Agreement 5
... October 20, 2011 PharmaVentures today announced the ... Essential Deal Trends: Oncology 2011 . This ... in developing and commercialising new drugs. The first report in ... single most active deal making therapeutic area in the pharmaceutical ...
... California, Berkeley, have turned a benign virus into ... collagen, one of the most important structural proteins ... be used to manufacture materials with tunable optical, ... led by Seung-Wuk Lee, UC Berkeley associate professor ...
... LAFAYETTE, Ind. - Researchers at Purdue University and the ... a device small enough to fit on a computer ... pulses, a technology that might have applications in more ... pulses repeat at very high rates, corresponding to hundreds ...
Cached Biology Technology:Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals' New Publication Series; Essential Deal Trends 2Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals' New Publication Series; Essential Deal Trends 3Researchers turn viruses into molecular Legos 2Researchers turn viruses into molecular Legos 3'Microring' device could aid in future optical technologies 2
(Date:6/18/2013)... a hacker lab. At Brandeis University, sophisticated computational ... helping scientists understand the complex interplay between genomic ... virus, outer "shell" critical for replication. ... we are finding will help researchers alter virus ... fellow Jason Perlmutter, first author of the scientific ...
(Date:6/18/2013)... June 18, 2013 Joshua Obar, Ph.D., Department of ... honored with a 2013 ICAAC Young Investigator Award for ... immunological memory responses to infection. , Obar earned ... 2001 and went on to complete his Ph.D. in ... He performed his Ph.D. thesis research in Edward Usherwood,s ...
(Date:6/18/2013)... refers to a chemical modification of DNA and ... in the DNA sequence. Until now, scientists believed ... of certain genes. Today, a team of researchers ... by Emmanouil Dermitzakis, Louis-Jeantet Professor at the Faculty ... the case and that DNA methylation may play ...
Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2The American Society for Microbiology honors Joshua Obar 2The secret of DNA methylation 2
... SALT LAKE CITY, Aug. 31, 2009 Researchers at ... shed new light on Ewing,s sarcoma, an often deadly bone ... shows that patients with poor outcomes have tumors with high ... the effects of chemotherapy. The research is published online today ...
... new molecular sensor that can reveal the amount of zinc in ... including type 2 diabetes. The research, published today in Nature ... biology by giving scientists an accurate way of measuring the concentration ... Zinc is involved in many processes in the body and ...
... Manipulating tiny objects like single cells or nanosized beads often ... uses sound as a tiny tweezers can be small enough ... , , "Current methods for moving individual cells or tiny ... lot of energy and could damage or even kill live ...
Cached Biology News:New hope for deadly childhood bone cancer 2Think zinc: Molecular sensor could reveal zinc's role in diseases 2Acoustic tweezers can position tiny objects 2Acoustic tweezers can position tiny objects 3
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
Tissue culture grade....
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
IHC detection kit for PCNA in cells and tissues...
Biology Products: